Anzeige
Meldung des Tages: Der 9,5 Mio. € Kupferfehler des Marktes – Und solche Fehler korrigieren sich schnell

Roche Holding Aktie (ADR) News

Aktie
WKN:  891106 ISIN:  US7711951043 US-Symbol:  RHHBY Branche:  Pharmazeutika Land:  Schweiz
55,29 $
+1,29 $
+2,39%
47,594 € 06.03.26
Depot/Watchlist
Marktkapitalisierung *
246,18 Mrd. €
Streubesitz
99,18%
KGV
11,84
Dividende
1,26 EUR
Dividendenrendite
2,89%
Faktor
8
Originalaktie
CH0012032048

Roche Holding Aktie (ADR) News

05.03.26 - PR Newswire
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
New survey demonstrates how diabetes limits day-​to-day freedom for people around the world and highlights need for predictive tools PR Newswire
16.12.25 - PR Newswire
Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities
Roche announces U.S. launch of next-​generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilities PR Newswire
12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
12.11.25 - PR Newswire
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche
Millennials at highest risk of missing crucial cervical cancer screenings, finds survey commissioned by Roche PR Newswire
13.10.25 - PR Newswire
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
Roche's Elecsys® pTau181 becomes the only FDA-​cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology PR Newswire
18.09.25 - PR Newswire
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Roche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test PR Newswire
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
16.09.25 - PR Newswire
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
Roche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience PR ...
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
05.09.25 - PR Newswire
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
Roche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients PR Newswire
24.07.25 - PR Newswire
Roche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
Roche Diagnostics showcases science-​driven leadership and innovation at ADLM 2025 PR Newswire
07.07.25 - PR Newswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs PR Newswire
07.07.25 - PR Newswire
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs PR Newswire
12.05.25 - PR Newswire
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
Roche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub PR Newswire
02.04.25 - PR Newswire
Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
Quest Diagnostics Introduces HPV Specimen Self-​Collection for Cervical Cancer Screening PR Newswire

Newssuche

Videos

newspaper
04.03.26 +13,80%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »